{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T07:01:49Z","timestamp":1790665309904,"version":"4.1.0"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2020,4,13]],"date-time":"2020-04-13T00:00:00Z","timestamp":1586736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,4,13]],"date-time":"2020-04-13T00:00:00Z","timestamp":1586736000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Transl Oncol"],"published-print":{"date-parts":[[2020,11]]},"DOI":"10.1007\/s12094-020-02345-3","type":"journal-article","created":{"date-parts":[[2020,4,13]],"date-time":"2020-04-13T13:02:31Z","timestamp":1586782951000},"page":"2040-2048","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["Radiation-induced lymphopenia: the main aspects to consider in immunotherapy trials for endometrial and cervical cancer patients"],"prefix":"10.1007","volume":"22","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7788-7602","authenticated-orcid":false,"given":"K.","family":"Holub","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Vargas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Biete","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,4,13]]},"reference":[{"key":"2345_CR1","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.critrevonc.2018.01.003","volume":"123","author":"BP Venkatesulu","year":"2018","unstructured":"Venkatesulu BP, Mallick S, Lin SH, Krishnan S. A systematic review of the influence of radiation-induced lymphopenia on survival outcomes in solid tumors. Crit Rev Oncol Hematol. 2018;123:42\u201351. https:\/\/doi.org\/10.1016\/j.critrevonc.2018.01.003.","journal-title":"Crit Rev Oncol Hematol"},{"key":"2345_CR2","doi-asserted-by":"publisher","first-page":"1225","DOI":"10.6004\/jnccn.2015.0151","volume":"13","author":"SA Grossman","year":"2015","unstructured":"Grossman SA, Ellsworth S, Campian J, Wild AT, Herman JM, Laheru D, et al. Survival in patients with severe lymphopenia following treatment with radiation and chemotherapy for newly diagnosed solid tumors. J Natl Compr Canc Netw. 2015;13:1225\u2013311.","journal-title":"J Natl Compr Canc Netw"},{"issue":"5","key":"2345_CR3","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1111\/j.1471-0528.1976.tb00851.x","volume":"83","author":"S Yamagata","year":"1976","unstructured":"Yamagata S, Green GH. Radiation-induced immune changes in patients with cancer of the cervix. Br J Obstet Gynaecol. 1976;83(5):400\u20138.","journal-title":"Br J Obstet Gynaecol"},{"issue":"3","key":"2345_CR4","first-page":"110","volume":"6","author":"LJ Standish","year":"2008","unstructured":"Standish LJ, Torkelson C, Hamill FA, et al. Immune defects in breast cancer patients after radiotherapy. J Soc Integr Oncol. 2008;6(3):110\u201321.","journal-title":"J Soc Integr Oncol"},{"issue":"2","key":"2345_CR5","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1016\/j.adro.2019.01.005","volume":"4","author":"MD Schad","year":"2019","unstructured":"Schad MD, Dutta SW, Muller DM, et al. Radiation-related lymphopenia after pelvic nodal irradiation for prostate cancer. Adv Radiat Oncol. 2019;4(2):323\u201330. https:\/\/doi.org\/10.1016\/j.adro.2019.01.005. (eCollection 2019 Apr-Jun)","journal-title":"Adv Radiat Oncol"},{"issue":"1","key":"2345_CR6","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1667\/RR15367.1","volume":"193","author":"SG Ellsworth","year":"2020","unstructured":"Ellsworth SG, Yalamanchali A, Zhang H, et al. Comprehensive analysis of the kinetics of radiation-induced lymphocyte loss in patients treated with external beam radiation therapy. Radiat Res. 2020;193(1):73\u201381. https:\/\/doi.org\/10.1667\/RR15367.1(Epub 2019 Nov 1).","journal-title":"Radiat Res"},{"key":"2345_CR7","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1016\/j.ygyno.2015.01.514","volume":"137","author":"T Herzog","year":"2015","unstructured":"Herzog T, Arguello D, Reddy S, et al. PD-1 and PD-L1 expression in 1599 gynecological malignancies: implications for immunotherapy. Gynecol Oncol. 2015;137:204\u20135.","journal-title":"Gynecol Oncol"},{"issue":"1","key":"2345_CR8","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/caac.21590","volume":"70","author":"RL Siegel","year":"2020","unstructured":"Siegel RL, Miller KD, Jemal A. Cancer statistics, 2020. CA Cancer J Clin. 2020;70(1):7\u201330. https:\/\/doi.org\/10.3322\/caac.21590(Epub 2020 Jan 8).","journal-title":"CA Cancer J Clin"},{"issue":"19","key":"2345_CR9","doi-asserted-by":"publisher","first-page":"4705","DOI":"10.3390\/ijms20194705","volume":"20","author":"E Grywalska","year":"2019","unstructured":"Grywalska E, Sobstyl M, Putowski L, et al. Current possibilities of gynecologic cancer treatment with the use of immune checkpoint inhibitors. Int J Mol Sci. 2019;20(19):4705. https:\/\/doi.org\/10.3390\/ijms20194705.","journal-title":"Int J Mol Sci"},{"issue":"3","key":"2345_CR10","doi-asserted-by":"publisher","first-page":"108","DOI":"10.3390\/healthcare7030108","volume":"7","author":"M Kagabu","year":"2019","unstructured":"Kagabu M, Nagasawa T, Fukagawa D, et al. Immunotherapy for uterine cervical cancer. Healthcare (Basel). 2019;7(3):108. https:\/\/doi.org\/10.3390\/healthcare7030108.","journal-title":"Healthcare (Basel)"},{"key":"2345_CR11","doi-asserted-by":"publisher","DOI":"10.1097\/GRF.0000000000000513","author":"S Lynam","year":"2019","unstructured":"Lynam S, Lugade AA, Odunsi K. Immunotherapy for gynecologic cancer: current applications and future directions. Clin Obstet Gynecol. 2019. https:\/\/doi.org\/10.1097\/GRF.0000000000000513.","journal-title":"Clin Obstet Gynecol"},{"issue":"1","key":"2345_CR12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/GCO.0000000000000603","volume":"32","author":"MM Rubinstein","year":"2020","unstructured":"Rubinstein MM, Makker V. Optimizing immunotherapy for gynecologic cancers. Curr Opin Obstet Gynecol. 2020;32(1):1\u20138. https:\/\/doi.org\/10.1097\/GCO.0000000000000603.","journal-title":"Curr Opin Obstet Gynecol"},{"issue":"1","key":"2345_CR13","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.ygyno.2015.11.013","volume":"140","author":"ES Wu","year":"2016","unstructured":"Wu ES, Oduyebo T, Cobb LP, et al. Lymphopenia and its association with survival in patients with locally advanced cervical cancer. Gynecol Oncol. 2016;140(1):76\u201382. https:\/\/doi.org\/10.1016\/j.ygyno.2015.11.013(Epub 2015 Nov 11).","journal-title":"Gynecol Oncol"},{"key":"2345_CR14","doi-asserted-by":"publisher","first-page":"114268","DOI":"10.18632\/oncotarget.23217","volume":"8","author":"A Diehl","year":"2017","unstructured":"Diehl A, Yarchoan M, Hopkins A, Jaffee EM, Grossman SA. Relationships between lymphocyte counts and treatment-related toxicities and clinical responses in patients with solid tumors treated with PD-1 checkpoint inhibitors. Oncotarget. 2017;8:114268.","journal-title":"Oncotarget"},{"key":"2345_CR15","doi-asserted-by":"publisher","first-page":"896","DOI":"10.3389\/fonc.2019.00896","volume":"9","author":"Y Zhuang","year":"2019","unstructured":"Zhuang Y, Yuan BY, Chen GW, et al. Association between circulating lymphocyte populations and outcome after stereotactic body radiation therapy in patients with hepatocellular carcinoma. Front Oncol. 2019;9:896. https:\/\/doi.org\/10.3389\/fonc.2019.00896(eCollection 2019).","journal-title":"Front Oncol"},{"issue":"5","key":"2345_CR16","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.1016\/j.ijrobp.2014.04.025","volume":"89","author":"C Tang","year":"2014","unstructured":"Tang C, Liao Z, Gomez D, et al. Lymphopenia association with gross tumor volume and lung V5 and its effects on non-small cell lung cancer patient outcomes. Int J Radiat Oncol Biol Phys. 2014;89(5):1084\u201391. https:\/\/doi.org\/10.1016\/j.ijrobp.2014.04.025.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1","key":"2345_CR17","doi-asserted-by":"publisher","first-page":"e16","DOI":"10.1016\/j.prro.2019.07.010","volume":"10","author":"PSN van Rossum","year":"2020","unstructured":"van Rossum PSN, Deng W, Routman DM. Prediction of Severe Lymphopenia During Chemoradiation Therapy for Esophageal Cancer: Development and Validation of a Pretreatment Nomogram. Pract Radiat Oncol. 2020;10(1):e16\u2013e26. https:\/\/doi.org\/10.1016\/j.prro.2019.07.010(Epub 2019 Jul 29).","journal-title":"Pract Radiat Oncol"},{"issue":"2","key":"2345_CR18","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1016\/j.ijrobp.2016.10.046","volume":"97","author":"AS Chadha","year":"2017","unstructured":"Chadha AS, Liu G, Chen HC, et al. Does unintentional splenic radiation predict outcomes after pancreatic cancer radiation therapy? Int J Radiat Oncol Biol Phys. 2017;97(2):323\u201332.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2345_CR19","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1093\/jnci\/djs629","volume":"105","author":"SC Formenti","year":"2013","unstructured":"Formenti SC, Demaria S. Combining radiotherapy and cancer immunotherapy: a paradigm shift. J Natl Cancer Inst. 2013;105:256\u201365.","journal-title":"J Natl Cancer Inst"},{"key":"2345_CR20","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.radonc.2019.12.023","volume":"145","author":"SP Ng","year":"2020","unstructured":"Ng SP, Bahig H, Jethanandani A, et al. Lymphopenia during radiotherapy in patients with oropharyngeal cancer. Radiother Oncol. 2020;145:95\u2013100. https:\/\/doi.org\/10.1016\/j.radonc.2019.12.023.","journal-title":"Radiother Oncol"},{"issue":"1","key":"2345_CR21","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1007\/s13277-015-3888-y","volume":"37","author":"O Cho","year":"2016","unstructured":"Cho O, Oh YT, Chun M, et al. Radiation-related lymphopenia as a new prognostic factor in limited-stage small cell lung cancer. Tumour Biol. 2016;37(1):971\u20138. https:\/\/doi.org\/10.1007\/s13277-015-3888-y(Epub 2015 Aug 12).","journal-title":"Tumour Biol"},{"issue":"1","key":"2345_CR22","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1186\/s40425-018-0395-x","volume":"6","author":"WJ Ho","year":"2018","unstructured":"Ho WJ, Yarchoan M. Hopkins A et al Association between pretreatment lymphocyte count and response to PD1 inhibitors in head and neck squamous cell carcinomas. J Immunother Cancer. 2018;6(1):84. https:\/\/doi.org\/10.1186\/s40425-018-0395-x.","journal-title":"J Immunother Cancer"},{"issue":"1","key":"2345_CR23","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1186\/s40425-018-0447-2","volume":"6","author":"AE Soyano","year":"2018","unstructured":"Soyano AE, Dholaria B, Marin-Acevedo JA, et al. Peripheral blood biomarkers correlate with outcomes in advanced non-small cell lung cancer patients treated with anti-PD-1 antibodies. J Immunother Cancer. 2018;6(1):129. https:\/\/doi.org\/10.1186\/s40425-018-0447-2.","journal-title":"J Immunother Cancer"},{"key":"2345_CR24","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.radonc.2019.11.014","volume":"144","author":"JY Jin","year":"2019","unstructured":"Jin JY, Mereniuk T, Yalamanchali A, et al. A framework for modeling radiation induced lymphopenia in radiotherapy. Radiother Oncol. 2019;144:105\u201313. https:\/\/doi.org\/10.1016\/j.radonc.2019.11.014.","journal-title":"Radiother Oncol"},{"issue":"7","key":"2345_CR25","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1016\/S1470-2045(17)30380-7","volume":"18","author":"N Shaverdian","year":"2017","unstructured":"Shaverdian N, Lisberg AE, Bornazyan K, Veruttipong D, Goldman JW, Formenti SC, et al. Previous radiotherapy and the clinical activity and toxicity of pembrolizumab in the treatment of non-small-cell lung cancer: a secondary analysis of the KEYNOTE-001 phase 1 trial. Lancet Oncol. 2017;18(7):895\u2013903.","journal-title":"Lancet Oncol"},{"key":"2345_CR26","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1016\/j.ejca.2017.07.033","volume":"84","author":"R Sun","year":"2017","unstructured":"Sun R, Champiat S, Dercle L, et al. Baseline lymphopenia should not be used as exclusion criteria in early clinical trials investigating immune checkpoint blockers (PD-1\/PD-L1 inhibitors). Eur J Cancer. 2017;84:202\u201311. https:\/\/doi.org\/10.1016\/j.ejca.2017.07.033(Epub 2017 Aug 18).","journal-title":"Eur J Cancer"},{"key":"2345_CR27","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.radonc.2018.12.002","volume":"133","author":"W Deng","year":"2019","unstructured":"Deng W, Xu C, Liu A, et al. The relationship of lymphocyte recovery and prognosis of esophageal cancer patients with severe radiation-induced lymphopenia after chemoradiation therapy. Radiother Oncol. 2019;133:9\u201315. https:\/\/doi.org\/10.1016\/j.radonc.2018.12.002(Epub 2019 Jan 11).","journal-title":"Radiother Oncol"},{"key":"2345_CR28","doi-asserted-by":"publisher","DOI":"10.1007\/s00066-019-01571-1","author":"T Tsuchiya","year":"2020","unstructured":"Tsuchiya T, Someya M, Takada Y, et al. Association between radiotherapy-induced alteration of programmed death ligand 1 and survival in patients with uterine cervical cancer undergoing preoperative radiotherapy. Strahlenther Onkol. 2020. https:\/\/doi.org\/10.1007\/s00066-019-01571-1.","journal-title":"Strahlenther Onkol"},{"issue":"1","key":"2345_CR29","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1186\/s12885-018-4136-9","volume":"18","author":"T Dov\u0161ak","year":"2018","unstructured":"Dov\u0161ak T, Ihan A, Didanovi\u010d V, et al. Effect of surgery and radiotherapy on complete blood count, lymphocyte subsets and inflammatory response in patients with advanced oral cancer. BMC Cancer. 2018;18(1):235. https:\/\/doi.org\/10.1186\/s12885-018-4136-9.","journal-title":"BMC Cancer"}],"container-title":["Clinical and Translational Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12094-020-02345-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12094-020-02345-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12094-020-02345-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,12]],"date-time":"2021-04-12T19:46:46Z","timestamp":1618256806000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12094-020-02345-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4,13]]},"references-count":29,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2020,11]]}},"alternative-id":["2345"],"URL":"https:\/\/doi.org\/10.1007\/s12094-020-02345-3","relation":{},"ISSN":["1699-048X","1699-3055"],"issn-type":[{"value":"1699-048X","type":"print"},{"value":"1699-3055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,4,13]]},"assertion":[{"value":"14 February 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 March 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 April 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}},{"value":"All procedures performed in our studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}